CoChat

The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010.

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. METHOD: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. RESULTS: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. CONCLUSION: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0116820

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Absolute DALYs Attributable to Mental, Neurological, and Substance Use Disorders, by Age, 2010.
Fig 1 Absolute DALYs Attributable to Mental, Neurological, and Substance Use Disorders, by Age, 2010.CC BY · PubMed Central
Fig 2 Age-Standardized DALY Rates Attributable to Individual Mental, Neurological, and Substance Use Disorders, by Gender, 2010.
Fig 2 Age-Standardized DALY Rates Attributable to Individual Mental, Neurological, and Substance Use Disorders, by Gender, 2010.CC BY · PubMed Central
Fig 3 Age-Standardized DALY Rates Attributable to Mental, Neurological, and Substance Use Disorders, by Region, 2010.
Fig 3 Age-Standardized DALY Rates Attributable to Mental, Neurological, and Substance Use Disorders, by Region, 2010.CC BY · PubMed Central
Fig 4 Proportion of Global YLDs and YLLs Attributable to Mental, Neurological, and Substance Use Disorders, 2010.
Fig 4 Proportion of Global YLDs and YLLs Attributable to Mental, Neurological, and Substance Use Disorders, 2010.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 1,175

Metadata

Authors
Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T.
Affiliations
  • The University of Queensland (AU)
  • The University of Melbourne (AU)
  • Auckland University of Technology (NZ)
  • University of Washington (US)
Corresponding author
Whiteford, Harvey A.
Venue
PLOS ONE
Published
2015-02-06
Volume
10
Issue
2
Pages
e0116820
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2006103193
Cited by
1,175
References
47
Citations by year
2026: 34 · 2025: 63 · 2024: 83 · 2023: 111 · 2022: 121 · 2021: 142 · 2020: 145 · 2019: 143 · 2018: 123 · 2017: 113 · 2016: 66 · 2015: 29
FWCI
180.47
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Bill and Melinda Gates Foundation
  • Australian Government
  • University of New South Wales
  • Medical Research Council
  • National Health and Medical Research Council (1041742)
  • National Drug and Alcohol Research Centre
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
mental illness, neurological disorders, substance use disorders, global burden of disease, disability-adjusted life years, years lived with disability, prevalence trends, sex differences, age differences, regional variation, schizophrenia, Parkinson's disease, epilepsy
MeSH terms
Age Factors, Bayes Theorem, Mental Disorders, Female, Geography, Humans, Male, Nervous System Diseases, Regression Analysis, Time Factors, Global Health, Prevalence, Cost of Illness, Quality-Adjusted Life Years, Substance-Related Disorders, Mortality, Premature

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010. https://app.cochat.ai/papers/10.1371/journal.pone.0116820
The paper
Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015). The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010. PLOS ONE. https://doi.org/10.1371/journal.pone.0116820

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.